Your browser doesn't support javascript.
loading
FDA Approval Summary: Belzutifan for von Hippel-Lindau Disease-Associated Tumors.
Fallah, Jaleh; Brave, Michael H; Weinstock, Chana; Mehta, Gautam U; Bradford, Diana; Gittleman, Haley; Bloomquist, Erik W; Charlab, Rosane; Hamed, Salaheldin S; Miller, Claudia P; Dorff, Sarah E; Chambers, Wiley A; Mixter, Bronwyn D; Dinin, Jeannette; Pierce, William F; Ricks, Tiffany K; Tang, Shenghui; Donoghue, Martha; Pazdur, Richard; Amiri-Kordestani, Laleh; Ibrahim, Amna; Beaver, Julia A.
Afiliación
  • Fallah J; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Brave MH; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Weinstock C; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Mehta GU; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Bradford D; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Gittleman H; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Bloomquist EW; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Charlab R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Hamed SS; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Miller CP; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Dorff SE; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Chambers WA; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Mixter BD; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Dinin J; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Pierce WF; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Ricks TK; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Tang S; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Donoghue M; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Pazdur R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Amiri-Kordestani L; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Ibrahim A; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Beaver JA; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
Clin Cancer Res ; 28(22): 4843-4848, 2022 11 14.
Article en En | MEDLINE | ID: mdl-35727604
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias del Sistema Nervioso Central / Tumores Neuroectodérmicos Primitivos / Hemangioblastoma / Enfermedad de von Hippel-Lindau / Neoplasias Renales / Antineoplásicos Tipo de estudio: Risk_factors_studies Límite: Adult / Female / Humans / Pregnancy Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias del Sistema Nervioso Central / Tumores Neuroectodérmicos Primitivos / Hemangioblastoma / Enfermedad de von Hippel-Lindau / Neoplasias Renales / Antineoplásicos Tipo de estudio: Risk_factors_studies Límite: Adult / Female / Humans / Pregnancy Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article